H J Harkins Company Inc dba Pharma Pac recalls Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins
Pharma Pac recalls 150mg Ranitidine tablets with NDMA impurity detected. Affected lots expire May 2024 through November 2024. Stop using immediately.
Stop using this now
CGMP Deviations: Presence of NDMA impurity detected in product.
Contact the company & request your remedy
What happened, in plain English
Pharma Pac is recalling 150mg Ranitidine tablets that contain NDMA impurity. This impurity has been detected in the product during manufacturing, and the recall is for safety reasons. Read more at govinfonow.com/recall/37489-pharma-pac-ranitidine-tablets-recall-ndma-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37489-pharma-pac-ranitidine-tablets-recall-ndma-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0793-2020
Cite this page
“Pharma Pac Ranitidine Tablets Recall: NDMA Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37489-pharma-pac-ranitidine-tablets-recall-ndma-impurity-risk. Based on FDA recall #D-0793-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0793-2020%22&limit=1).
Why it’s dangerous
NDMA (N-nitrosodimethylamine) is a potential carcinogen that can form in certain chemical processes. The presence of this impurity in the product raises safety concerns due to possible long-term health risks.
Who’s affected
People who have the recalled 150mg Ranitidine tablets (7-count to 60-count) from Pharma Pac. Those with the specific lot numbers and expiration dates listed are most at risk.
How to tell if you have this one
Check for the product name 'Ranitidine 150 mg Tablets' with counts from 7 to 60. Look for lot numbers RAN63KG (exp. 05/20), RAN64KG (exp. 10/20), RAN65KG (exp. 11/20), or RAN66KG (exp. 05/21).
- Brand
Pharma Pac- Category
Drug
What to do — step by step
Stop Using Immediately
Discard all recalled Ranitidine tablets with the specified lot numbers and expiration dates.
Questions people ask
Why is this product being recalled?
Pharma Pac detected NDMA impurity in the product during manufacturing, which is a potential carcinogen.
What is the specific risk from this impurity?
NDMA is a potential carcinogen that can form in certain chemical processes, raising safety concerns for long-term health.
How do I know if I have the recalled product?
Check for the product name 'Ranitidine 150 mg Tablets' with counts from 7 to 60 and lot numbers RAN63KG through RAN66KG with specific expiration dates.
Contact Pharma Pac
We’ve drafted a message you can send Pharma Pac to request your refund or repair — edit it as you like.
Subject: Recall D-0793-2020 — Pharma Pac Pharma Pac Hello, I own a Pharma Pac that is covered by recall D-0793-2020 from Pharma Pac. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0793-2020 (January 6, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0793-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.